LRP1B and early-onset autosomal dominant Alzheimer disease: LRP1B was recently identified as an essential mediator of C1q-induced protection against β-amyloid neurotoxicity in Alzheimer’s disease mouse models [25], which partly explains how ACE inhibitors reduce β-amyloid-dependent neurodegeneration [26].